Literature DB >> 6431299

Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide.

C J Marshall, K H Vousden, D H Phillips.   

Abstract

Chemical carcinogenesis generally proceeds via the formation of strongly electrophilic reactants, termed ultimate carcinogens. The observation that many ultimate carcinogens are potent mutagens and the results of studies on the covalent binding of carcinogens to cellular macromolecules suggest that tumour initiation results from mutations arising from the binding of ultimate carcinogens to DNA. Recently, gene transfer experiments have shown that some tumours contain activated oncogenes which are members of the ras gene family (reviewed in refs 6. 7) and which differ by single base pair substitutions from their non-transforming counterparts, the proto-oncogenes (see, for example, refs 8-11). Here we have used clones of the c-Ha-ras-1 proto-oncogene to show that reaction in vitro with an ultimate carcinogen generates a transforming oncogene when the modified DNA is introduced into NIH 3T3 cells. As DNA is the only cellular macromolecule present in the reactions, our experiments also show that reaction of an ultimate carcinogen with DNA alone can lead to the induction of mutations in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431299     DOI: 10.1038/310586a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  27 in total

1.  Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) by PAH o-quinones: involvement of reactive oxygen species and copper(II)/copper(I) redox cycling.

Authors:  Jong-Heum Park; Sridhar Gopishetty; Lawrence M Szewczuk; Andrea B Troxel; Ronald G Harvey; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2005-06       Impact factor: 3.739

2.  Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors.

Authors:  S Dandekar; S Sukumar; H Zarbl; L J Young; R D Cardiff
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

3.  Case-control study of hydrocarbon exposures in patients with renal cell carcinoma.

Authors:  C R Sharpe; J E Rochon; J M Adam; S Suissa
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

4.  Genomic hypomethylation and far-5' sequence alterations are associated with carcinogen-induced activation of the hamster thymidine kinase gene.

Authors:  F G Barr; S Rajagopalan; C A MacArthur; M W Lieberman
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

5.  Site-specific carcinogen binding to DNA in polytene chromosomes.

Authors:  P D Kurth; M Bustin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

Review 6.  DNA adducts in experimental cancer research.

Authors:  K Hemminki; A Försti; R Mustonen; K Savela
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Urinary excretion of mutagens and covalent DNA damage induced in the bladder and kidney after passive smoking in rats.

Authors:  J Takenawa; Y Kaneko; K Okumura; H Nakayama; J Fujita; O Yoshida
Journal:  Urol Res       Date:  1994

8.  Characterization of mutagen-activated cellular oncogenes that confer anchorage independence to human fibroblasts and tumorigenicity to NIH 3T3 cells: sequence analysis of an enzymatically amplified mutant HRAS allele.

Authors:  C W Stevens; T H Manoharan; W E Fahl
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Mutations activating human c-Ha-ras1 protooncogene (HRAS1) induced by chemical carcinogens and depurination.

Authors:  K H Vousden; J L Bos; C J Marshall; D H Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 10.  Biomarkers of induced active and passive smoking damage.

Authors:  Maura Lodovici; Elisabetta Bigagli
Journal:  Int J Environ Res Public Health       Date:  2009-02-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.